4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. Leveraging its proprietary XV Technology and Imbio Technology, the Company provides cutting-edge thoracic imaging that enhances physician diagnoses and management of respiratory conditions. XV technology delivers detailed insights to airflow, lung structure, and regional lung function through a patient’s complete breath cycle. The company produces software and hardware products that enable new levels of non-invasive, quantitative analysis of lung function. Its products include CAC (Coronary Artery Calcification), CT-LVAS (Computed Tomography Lung Ventilation Analysis Software), IQ-UIP, LDAf (Functional Lung Density Analysis), LDAi (Lung Density Analysis-Inspiration), LTA (Lung Texture Analysis), PHA Analysis (Pulmonary Hypertension Assessment), XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software), and XV Scanner.
What is the price performance of 4DMEDICAL LTD stock?
The current price of 4DMEDICAL LTD is $3.16, it has decreased 0% in the last trading day.
What are the primary business themes or industries for 4DMedical Limited?
4DMedical Limited belongs to Health Care industry and the sector is Health Care
What is 4DMedical Limited market cap?
4DMedical Limited's current market cap is $1.8B
Is 4DMedical Limited a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for 4DMedical Limited, including 2 strong buy, 3 buy, 1 hold, 0 sell, and 2 strong sell